-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a report released on Thursday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.00 on Thursday. Navidea Biopharmaceuticals has a 12-month low of $0.00 and a 12-month high of […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a report released on Thursday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.00 on Thursday. Navidea Biopharmaceuticals has a 12-month low of $0.00 and a 12-month high of […]
